Skip to main content
Fig. 11 | BMC Complementary Medicine and Therapies

Fig. 11

From: Combination of bioaffinity ultrafiltration-UFLC-ESI-Q/TOF-MS/MS, in silico docking and multiple complex networks to explore antitumor mechanism of topoisomerase I inhibitors from Artemisiae Scopariae Herba

Fig. 11

Topo I inhibitory binding assay by agarose gel electrophoresis. Lane “D” represents pure pBR322 DNA (0.175 µg). “T” is the mixture of topo I (0.5 U) and pBR322 DNA (0.175 µg). The same amounts of topo I and DNA were added to all the other lanes. Lanes “A” represents the addition of ASH extract (2.0 µg), and that “C” indicates camptothecin (1.4 µg, positive control). Lanes “M”, “Q”, “I”, represent the addition of the mixture of 1.0 µg quercetin and 1.4 µg isorhamnetin, quercetin (1.0 µg), isorhamnetin (1.4 µg), respectively

Back to article page